Vulnerable and elderly Australians are missing out on protection against respiratory syncytial virus (RSV) because many can’t ...

PFE's non-COVID drugs and contributions from new and newly acquired products are likely to have driven top-line growth in the ...

The estimated effectiveness of the respiratory syncytial virus (RSV) among older US veterans in the 2023-2024 respiratory ...

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

This week we welcomed the federal government's announcement that a respiratory syncytial virus (RSV) vaccine for pregnant women would be included on ...

In 2024, companies in the broader market that paid dividends returned around 35% of their net income and 45% of their free ...

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

The prescribing information for Abrysvo ® (respiratory syncytial virus [RSV] vaccine) and Arexvy ® (RSV vaccine, adjuvanted) has been updated to include a new warning regarding the risk of ...

We recently compiled a list of the 10 Best High-Yield Dividend Stocks To Invest In. In this article, we are going to take a ...

With illness activity high, everyone 6 months and older is urged to get vaccinated against respiratory viruses.

Merit Financial Group LLC grew its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 60.8% during the fourth quarter, ...

The Malinauskas Labor Government is partnering with the Albanese Federal Government to provide the infant component of the new National RSV Maternal ...